Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,088 ILa | -2.33% | -3.46% | +134.94% |
May. 01 | InterCure Ltd. Provides Revenue Guidance for the Full Year 2024 | CI |
May. 01 | InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+134.94% | 137M | |
-.--% | 339M | |
+24.69% | 245M | |
+10.31% | 228M | |
+36.05% | 177M | |
-28.57% | 121M | |
+32.61% | 120M | |
-47.02% | 111M | |
-.--% | 87.2M | |
+150.00% | 75.33M |
- Stock Market
- Equities
- INCR Stock
- News InterCure Ltd.
- Novellusdx Ltd. announced that it has received $12.5 million in funding from Pontifax Ltd., InterCure Ltd., OrbiMed Advisors, L.L.C.